When we stratified the patients according to the menopause status (190 pre-menopausal and 118 post-menopausal) no significant changes in the LEP and LEPR genotype distributions were seen in breast carcinoma subgroups (data not shown). This evidence concerns the gene LEP and breast carcinoma.